Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
1.750
-0.140 (-7.41%)
At close: Dec 20, 2024, 4:00 PM
1.820
+0.070 (4.00%)
After-hours: Dec 20, 2024, 7:13 PM EST
Virax Biolabs Group Market Cap
Virax Biolabs Group has a market cap or net worth of $7.60 million as of December 20, 2024. Its market cap has increased by 149.10% in one year.
Market Cap
7.60M
Enterprise Value
820.09K
1-Year Change
149.10%
Ranking
Category
Stock Price
$1.75
Market Cap Chart
Since the IPO on July 21, 2022, Virax Biolabs Group's market cap has decreased from $207.01M to $7.60M, a decrease of -96.33%. That is a compound annual growth rate of -74.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 7.60M | 187.29% |
| Dec 29, 2023 | 2.64M | -71.76% |
| Dec 30, 2022 | 9.36M | -95.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aytu BioPharma | 8.49M |
| QT Imaging Holdings | 8.44M |
| BioCardia | 8.44M |
| RedHill Biopharma | 8.29M |
| Dominari Holdings | 8.23M |
| CERo Therapeutics Holdings | 8.12M |
| Meihua International Medical Technologies | 8.04M |
| NeuroMetrix | 7.97M |